AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Publishersweekly

Published November 7, 2026

AAR/SBL 2026: Jaime Clark-Soles Says Amen to Psychedelics - Publishers Weekly

Read the full story at Publishersweekly

The New Testament scholar and theologian addresses the rising interest in psychedelics, such as psilocybin and LSD , and why the church must enter.

Post on X

Share this story

Surfaced by this Google Alert